 |
Autologous incubated macrophage |
|---|---|
| Trade Name | |
| Orphan Indication | Therapy to improve the motor and sensory neurological outcome in acute cases of spinal cord injury |
| USA Market Approval | USA |
| USA Designation Date | 2004-09-03 00:00:00 |
| Sponsor | Proneuron Biotechnologies, Inc.;2029 Century Park East, Sixth Floor;Los Angeles, California, 90067 |
